Aditya Bansal, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · New Orleans, LANPI 1922219815
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 75.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $73,189 and has fallen 99.4% since, to $419 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $587.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$106K
- Livanova USA, Inc.$27K
- Abiomed$6K
- Medtronic$753
- Cvrx, Inc.$348
- Corcym Inc$39
Across 72 payments — averaging $7337.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$528K
What the payments were for
- Consulting fees$73,69053%
- Speaking & faculty fees$32,88024%
- Travel & lodging$27,05519%
- Food & beverage$6,2074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 171 | $105,698 |
| Livanova USA, Inc. | 17 | $26,981 |
| Abiomed | 32 | $6,012 |
| Medtronic(2 entities) | 13 | $753 |
| Cvrx, Inc. | 3 | $348 |
| Corcym Inc | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HeartMate 3 Left Ventricular Dev$45,544
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$31,904
- TandemLife$26,625
- CardioMEMS HF System$9,500
- CentriMag$8,914
- Impella$5,077
- HeartMate 3 Left Ventricular Assist Device$3,500
- CARDIOMEMS$2,125
- HeartMate Touch$1,181
- 2ND GEN CENTRIMAG PRIMARY CONSOLE$500
- Barostim Neo System$300
- Avalus$288
- TandemHeart$229
- Mosaic$125
- HeartWare HVAD$118
How this compares
$139,832 in reported general payments places this provider in the 90th percentile of 75 thoracic surgery (cardiothoracic vascular surgery) providers in Louisiana.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in New Orleans
- Brian PettifordNew Orleans$35K
- Korie JonesNew Orleans$19K
- Patrick ParrinoNew Orleans$11K
- William RisherNew Orleans$7K
- Stephen SpindelNew Orleans$6K
- Jordan DozierNew Orleans$5K
- Eugene KukuyNew Orleans$4K
- Michael WeaverNew Orleans$3K
- Inder MehtaNew Orleans$3K
- Saket SinghNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.